Balyasny Asset Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,628	Closed	-$2.63M	–	2178
2021 Q2	$2.63M	Hold	10,628	–	–	0.01%	828
2021 Q1	$2.58M	Buy	+10,628	New	+$2.58M	0.01%	786